Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shugufta Khan"'
Autor:
Xiaoting Zhang, Elyse E. Lower, Jiang Wang, Shugufta Khan, Charif Mahmoud, Dan Zhao, Yijuan Zhang, Marissa Leonard, Yongguang Yang
Studies of the estrogen receptor (ER) coactivator protein Mediator subunit 1 (MED1) have revealed its specific roles in pubertal mammary gland development and potential contributions to breast tumorigenesis, based on coamplification of MED1 and HER2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3994d725d906c9285af021e262b06035
https://doi.org/10.1158/0008-5472.c.6509763
https://doi.org/10.1158/0008-5472.c.6509763
Autor:
Xiaoting Zhang, Elyse E. Lower, Jiang Wang, Shugufta Khan, Charif Mahmoud, Dan Zhao, Yijuan Zhang, Marissa Leonard, Yongguang Yang
Supplementary Information - This file contains Supplemental Procedures, Supplemental References, Supplemental Table1, Supplementary Figure Legends, and Supplementary Figures. Supplemental Procedure describes the methods and PCR primers used in this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad1c6ca7fdf4f39333d7fb651b6c27c
https://doi.org/10.1158/0008-5472.22417173.v1
https://doi.org/10.1158/0008-5472.22417173.v1
Autor:
Mounika Yeladandi, Sunanda Chavva, Swetha Bindu Padala, Shugufta Khanam, Harika Vemula, Himapriya Moparthi
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 03, Pp 01-06 (2024)
Introduction: Temporomandibular Joint Disorders (TMDs) are considered multifactorial, and several treatment approaches have been proposed for their effective management. The use of non invasive treatment modalities is recommended, which includes Tran
Externí odkaz:
https://doaj.org/article/1de0b2e091174e8998723e32f0be9e33
Autor:
Marissa Leonard, Xiaoting Zhang, Charif Mahmoud, Elyse E. Lower, Dan Zhao, Yijuan Zhang, Yongguang Yang, Jiang Wang, Shugufta Khan
Publikováno v:
Cancer Research. 78:422-435
Studies of the estrogen receptor (ER) coactivator protein Mediator subunit 1 (MED1) have revealed its specific roles in pubertal mammary gland development and potential contributions to breast tumorigenesis, based on coamplification of MED1 and HER2
Autor:
Mounika Yeladandi, T N Uma Maheswari, Nallan CS K Chaitanya, Swetha Bindu Padala, Chennuri Keerthi Prasanna, R Amritha Sripoo, Shugufta Khanam, M Dhanya
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 15, Iss 5, Pp 93-97 (2023)
Oral squamous cell carcinomas (OSCCs) fall between the sixth and eighth most common cancers. The prevention of cancer and the treatment of the disease depends on early diagnosis. To encourage dental professionals to use light-based detection techniqu
Externí odkaz:
https://doaj.org/article/cb8eb10a4cda460cb1e4b3306fe9ff8b
Autor:
Xiaoting Zhang, Harriet Kumar, Mahmoud Charif, Shugufta Khan, Elyse E. Lower, Neetu Radhakrishnan, Diane Kennedy
Publikováno v:
Cancer Research. 75:P3-05
Background: Fulvestrant is a well-established treatment for postmenopausal patients with estrogen receptor (ER) positive metastatic breast cancer, and some patients experience prolonged clinical benefit exceeding one year. HER2 activation is a major
Autor:
Diane Kennedy, Mahmoud Charif, Neetu Radhakrishnan, Elyse E. Lower, Xiaoting Zhang, Harriet Kumar, Shugufta Khan
Publikováno v:
Journal of Clinical Oncology. 32:155-155
155 Background: Overexpression of HER2/neu is associated with tamoxifen resistance in breast cancer (Osborne CK et al. J Natl Canc Inst 2003; 95:353-361). However pts may present with both estrogen receptor (ER) and HER2/neu + tumors. The benefit of